Cargando…

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Detalles Bibliográficos
Autores principales:	Zhou, Ru, Yazdanifar, Mahboubeh, Roy, Lopamudra Das, Whilding, Lynsey M., Gavrill, Artemis, Maher, John, Mukherjee, Pinku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750685/ https://www.ncbi.nlm.nih.gov/pubmed/33365036 http://dx.doi.org/10.3389/fimmu.2020.628776

Ejemplares similares

CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
por: Zhou, Ru, et al.
Publicado: (2019)

Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma
por: Yazdanifar, Mahboubeh, et al.
Publicado: (2019)

A Novel Association of Neuropilin-1 and MUC1 in Pancreatic Ductal Adenocarcinoma: Role in Induction of VEGF Signaling and Angiogenesis
por: Zhou, Ru, et al.
Publicado: (2016)

Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma
por: Bose, Mukulika, et al.
Publicado: (2022)

MUC1 Regulates PDGFA Expression During Pancreatic Cancer Progression
por: Sahraei, Mahnaz, et al.
Publicado: (2012)

Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice
por: Curry, Jennifer M., et al.
Publicado: (2019)

Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models
por: Sahraei, Mahnaz, et al.
Publicado: (2021)

Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors()()
por: Moore, Laura Jeffords, et al.
Publicado: (2016)

Preclinical evaluation of an (111)In/(225)Ac theranostic targeting transformed MUC1 for triple negative breast cancer
por: Kelly, Vanessa J, et al.
Publicado: (2020)

Pancreatic Cancer Cells Isolated from Muc1-Null Tumors Favor the Generation of a Mature Less Suppressive MDSC Population
por: Kidiyoor, Amritha, et al.
Publicado: (2014)

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
por: Roy, Lopamudra Das, et al.
Publicado: (2010)

Generation of human parallel chimeric antigen receptor (pCAR) T cells to achieve synergistic T cell co-stimulation
por: Larcombe-Young, Daniel, et al.
Publicado: (2022)

Potential of Anti-MUC1 Antibodies as a Targeted Therapy for Gastrointestinal Cancers
por: Bose, Mukulika, et al.
Publicado: (2020)

Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer
por: Nath, Sritama, et al.
Publicado: (2015)

Exacerbated metastatic disease in a mouse mammary tumor model following latent gammaherpesvirus infection
por: Chauhan, Vinita S, et al.
Publicado: (2012)

SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line
por: Grover, Priyanka, et al.
Publicado: (2018)

CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies
por: Whilding, Lynsey M., et al.
Publicado: (2019)

MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer
por: Roy, Lopamudra Das, et al.
Publicado: (2011)

Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches
por: Roy, Lopamudra Das, et al.
Publicado: (2014)

A tumor specific antibody to aid breast cancer screening in women with dense breast tissue
por: Roy, Lopamudra Das, et al.
Publicado: (2017)

Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis
por: Das Roy, Lopamudra, et al.
Publicado: (2009)

Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer
por: Goode, Gennifer, et al.
Publicado: (2017)

Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling
por: Roy, Lopamudra Das, et al.
Publicado: (2013)

Hurdles to breakthrough in CAR T cell therapy of solid tumors
por: Marofi, Faroogh, et al.
Publicado: (2022)

Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma
por: Dréau, Didier, et al.
Publicado: (2019)

Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression
por: Yamashita, Nami, et al.
Publicado: (2022)

CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
por: Marofi, Faroogh, et al.
Publicado: (2021)

Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes
por: Pathangey, Latha B., et al.
Publicado: (2016)

Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles
por: Wu, Shu-ta, et al.
Publicado: (2018)

Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
por: Hiraki, Masayuki, et al.
Publicado: (2018)

Synergy between liposomal zoledronic acid and γδ T-cells in the treatment of epithelial ovarian cancer
por: Pereira, Ana Catarina Parente, et al.
Publicado: (2013)

CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil
por: Nasiri, Fatemeh, et al.
Publicado: (2022)

CAR‐NK cell in cancer immunotherapy; A promising frontier
por: Marofi, Faroogh, et al.
Publicado: (2021)

Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review
por: Slepicka, Priscila Ferreira, et al.
Publicado: (2021)

Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer
por: Yamashita, Nami, et al.
Publicado: (2022)

Biodegradable PEG-PCL Nanoparticles for Co-delivery of MUC1 Inhibitor and Doxorubicin for the Confinement of Triple-Negative Breast Cancer
por: Behl, Akanksha, et al.
Publicado: (2022)

MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells
por: Yamashita, Nami, et al.
Publicado: (2023)

MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
por: Mei, Zi, et al.
Publicado: (2019)

EXPRESSION OF MUC2 GLYCOPROTEIN ANTIBODY AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN BARRETT’S MUCOSA
por: Ražov Radas, Melanija
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ffi5l0h5gm0mijo1nlfk3e4coa